A Critical Role for Stat3 Signaling in Immune Tolerance-Reference-Cited by-同舟云学术

A Critical Role for Stat3 Signaling in Immune Tolerance

Published:2003-09 Issue:3 Volume:19 Page:425-436
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Cheng Fengdong,Wang Hong-Wei,Cuenca Alex,Huang Mei,Ghansah Tomar,Brayer Jason,Kerr William G.,Takeda Kiyoshi,Akira Shizuo,Schoenberger Stephen P.,Yu Hua,Jove Richard,Sotomayor Eduardo M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference35 articles.

1. CD4(+) T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells;Adler;J. Exp. Med.,1998

2. Dendritic cells and the control of immunity;Banchereau;Nature,1998

3. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements;Barnden;Immunol. Cell Biol.,1998

4. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens;Belz;J. Exp. Med.,2002

5. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression;Benkhart;J. Immunol.,2000

Cited by 326 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obovatol inhibits proliferation, invasion and immune escape of hepatocellular carcinoma cells through modulating the JAK/STST3/PD-L1 pathway;International Immunopharmacology;2024-11

2. Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma;Frontiers in Immunology;2024-08-21

3. Interleukin 4 and cancer resistance in glioblastoma multiforme;Neurosurgical Review;2024-08-21

4. Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours;Frontiers in Immunology;2024-08-05

5. Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors;Frontiers in Immunology;2024-04-05